Jeremy C. Parker

2.1k total citations
34 papers, 1.1k citations indexed

About

Jeremy C. Parker is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Cellular and Molecular Neuroscience. According to data from OpenAlex, Jeremy C. Parker has authored 34 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 11 papers in Endocrinology, Diabetes and Metabolism and 10 papers in Cellular and Molecular Neuroscience. Recurrent topics in Jeremy C. Parker's work include Diabetes Treatment and Management (10 papers), Neuropeptides and Animal Physiology (7 papers) and Receptor Mechanisms and Signaling (6 papers). Jeremy C. Parker is often cited by papers focused on Diabetes Treatment and Management (10 papers), Neuropeptides and Animal Physiology (7 papers) and Receptor Mechanisms and Signaling (6 papers). Jeremy C. Parker collaborates with scholars based in United Kingdom, United States and Malaysia. Jeremy C. Parker's co-authors include Victor A. Gault, Finbarr O’Harte, Surendran Thavagnanam, Michael D. Shields, Liam G. Heaney, Grzegorz Skibiński, Peter R. Flatt, Patrick Harriott, Greg J. Barritt and Ultan F. Power and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Jeremy C. Parker

34 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeremy C. Parker United Kingdom 20 398 391 350 207 203 34 1.1k
Lorin K. Johnson United States 17 189 0.5× 574 1.5× 180 0.5× 89 0.4× 189 0.9× 30 1.3k
D. Banerjee United States 18 216 0.5× 457 1.2× 209 0.6× 271 1.3× 152 0.7× 33 1.3k
Vasily M. Gelfanov United States 19 347 0.9× 866 2.2× 665 1.9× 31 0.1× 97 0.5× 49 1.7k
G. Skude Sweden 19 362 0.9× 182 0.5× 122 0.3× 135 0.7× 158 0.8× 56 1.0k
Ghislaine Fontès Canada 19 680 1.7× 600 1.5× 363 1.0× 34 0.2× 149 0.7× 33 1.4k
Yi Hu China 19 124 0.3× 385 1.0× 239 0.7× 69 0.3× 122 0.6× 60 1.1k
Ryosuke Nakano Japan 21 112 0.3× 528 1.4× 196 0.6× 51 0.2× 81 0.4× 82 1.4k
Xiaoming Li China 22 160 0.4× 246 0.6× 184 0.5× 39 0.2× 537 2.6× 59 1.2k
Leona Wagner Germany 19 113 0.3× 478 1.2× 370 1.1× 49 0.2× 78 0.4× 37 1.4k
Hideo Fukui Japan 17 241 0.6× 363 0.9× 59 0.2× 63 0.3× 151 0.7× 47 1.0k

Countries citing papers authored by Jeremy C. Parker

Since Specialization
Citations

This map shows the geographic impact of Jeremy C. Parker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeremy C. Parker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeremy C. Parker more than expected).

Fields of papers citing papers by Jeremy C. Parker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeremy C. Parker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeremy C. Parker. The network helps show where Jeremy C. Parker may publish in the future.

Co-authorship network of co-authors of Jeremy C. Parker

This figure shows the co-authorship network connecting the top 25 collaborators of Jeremy C. Parker. A scholar is included among the top collaborators of Jeremy C. Parker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeremy C. Parker. Jeremy C. Parker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Parker, Jeremy C., Isobel Douglas, Jennifer M. Bell, et al.. (2015). Epidermal Growth Factor Removal or Tyrphostin AG1478 Treatment Reduces Goblet Cells & Mucus Secretion of Epithelial Cells from Asthmatic Children Using the Air-Liquid Interface Model. PLoS ONE. 10(6). e0129546–e0129546. 3 indexed citations
2.
Thavagnanam, Surendran, et al.. (2014). Nasal Epithelial Cells Can Act as a Physiological Surrogate for Paediatric Asthma Studies. PLoS ONE. 9(1). e85802–e85802. 34 indexed citations
3.
Parker, Jeremy C., Surendran Thavagnanam, Grzegorz Skibiński, et al.. (2013). Chronic IL9 and IL-13 Exposure Leads to an Altered Differentiation of Ciliated Cells in a Well-Differentiated Paediatric Bronchial Epithelial Cell Model. PLoS ONE. 8(5). e61023–e61023. 37 indexed citations
4.
5.
Thavagnanam, Surendran, et al.. (2010). Effects of IL-13 on Mucociliary Differentiation of Pediatric Asthmatic Bronchial Epithelial Cells. Pediatric Research. 69(2). 95–100. 37 indexed citations
6.
Craig, Thelma, Michael Duffy, Murali Shyamsundar, et al.. (2009). BTS/BLF/BALR young investigators symposium. Thorax. 64(Suppl 4). A2–A4. 1 indexed citations
7.
Zhang, Hengtao, Jeremy C. Parker, Neal Shepherd, & Tony L. Creazzo. (2009). Developmental expression of a functional TASK-1 2P domain K+ channel in embryonic chick heart. Journal of Biomedical Science. 16(1). 104–104. 3 indexed citations
8.
Parker, Jeremy C., Séverine Sarlang, Surendran Thavagnanam, et al.. (2009). A 3-D Well-Differentiated Model of Pediatric Bronchial Epithelium Demonstrates Unstimulated Morphological Differences Between Asthmatic and Nonasthmatic Cells. Pediatric Research. 67(1). 17–22. 55 indexed citations
9.
Corbett, Jeffrey W., Kenneth J. DiRico, Brian P. Boscoe, et al.. (2007). Design and synthesis of potent amido- and benzyl-substituted cis-3-amino-4-(2-cyanopyrrolidide)pyrrolidinyl DPP-IV inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(24). 6707–6713. 20 indexed citations
10.
Parker, Jeremy C., Victor A. Gault, Peter R. Flatt, et al.. (2006). NMR and Alanine Scan Studies of Glucose-dependent Insulinotropic Polypeptide in Water. Journal of Biological Chemistry. 281(24). 16370–16376. 36 indexed citations
11.
Irwin, Nigel, Brian D. Green, Jeremy C. Parker, et al.. (2006). Biological activity and antidiabetic potential of synthetic fragment peptides of glucose-dependent insulinotropic polypeptide, GIP(1-16) and (Pro3)GIP(1-16). Regulatory Peptides. 135(1-2). 45–53. 12 indexed citations
12.
13.
Hewage, Chandralal M., et al.. (2004). NMR structure of the glucose-dependent insulinotropic polypeptide fragment, GIP(1–30)amide. Biochemical and Biophysical Research Communications. 325(1). 281–286. 17 indexed citations
14.
O’Harte, Finbarr, Victor A. Gault, Jeremy C. Parker, et al.. (2002). Improved stability, insulin-releasing activity and antidiabetic potential of two novel N-terminal analogues of gastric inhibitory polypeptide: N-acetyl-GIP and pGlu-GIP. Diabetologia. 45(9). 1281–1291. 58 indexed citations
15.
Gault, Victor A., Jeremy C. Parker, Patrick Harriott, Peter R. Flatt, & Finbarr O’Harte. (2002). Evidence that the major degradation product of glucose-dependent insulinotropic polypeptide, GIP(3-42), is a GIP receptor antagonist in vivo. Journal of Endocrinology. 175(2). 525–533. 89 indexed citations
16.
Lassiter, Herbert A., et al.. (2000). Complement depletion with cobra venom factor reduces post-hypoxic-ischemic cerebral edema in neonatal rats. Journal of Investigative Medicine. 48(1). 152. 1 indexed citations
17.
Parker, Jeremy C., R. Kirk McPherson, Kim Andrews, et al.. (2000). Effects of skyrin, a receptor-selective glucagon antagonist, in rat and human hepatocytes.. Diabetes. 49(12). 2079–2086. 46 indexed citations
18.
Parker, Jeremy C., Kim Andrews, Walter Massefski, et al.. (1998). Structure‐function analysis of a series of glucagon‐like peptide‐1 analogs. Journal of Peptide Research. 52(5). 398–409. 31 indexed citations
19.
Parker, Jeremy C., et al.. (1985). Enalapril???lnduced Secretion of Active and Inactive Renin. Journal of Hypertension. 3(6). 667–668. 1 indexed citations
20.
Tiwary, Chandra M., et al.. (1975). Effects of Thyrotropin-Releasing Hormone in Minimal Brain Dysfunction. PEDIATRICS. 56(1). 119–121. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lorin K. Johnson Breakdown of academic impact, for papers by D. Banerjee Breakdown of academic impact, for papers by Vasily M. Gelfanov Breakdown of academic impact, for papers by G. Skude Breakdown of academic impact, for papers by Ghislaine Fontès Breakdown of academic impact, for papers by Yi Hu Breakdown of academic impact, for papers by Ryosuke Nakano Breakdown of academic impact, for papers by Xiaoming Li Breakdown of academic impact, for papers by Leona Wagner Breakdown of academic impact, for papers by Hideo Fukui
Rankless by CCL
2026